157 related articles for article (PubMed ID: 23266723)
1. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.
Walker GV; Gilbert MR; Prabhu SS; Brown PD; McAleer MF
J Neurooncol; 2013 Mar; 112(1):83-9. PubMed ID: 23266723
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 cases.
Rath GK; Sharma DN; Mallick S; Gandhi AK; Joshi NP; Haresh KP; Gupta S; Julka PK
Indian J Cancer; 2015; 52(4):599-603. PubMed ID: 26960490
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
[TBL] [Abstract][Full Text] [Related]
4. Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.
Mallick S; Gandhi AK; Sharma DN; Gupta S; Haresh KP; Rath GK; Julka PK
Childs Nerv Syst; 2015 Dec; 31(12):2341-4. PubMed ID: 26438548
[TBL] [Abstract][Full Text] [Related]
5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
6. Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.
Gerstein J; Franz K; Steinbach JP; Seifert V; Rödel C; Weiss C
Strahlenther Onkol; 2011 Nov; 187(11):722-8. PubMed ID: 22037649
[TBL] [Abstract][Full Text] [Related]
7. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.
Cao JQ; Fisher BJ; Bauman GS; Megyesi JF; Watling CJ; Macdonald DR
J Neurooncol; 2012 Apr; 107(2):395-405. PubMed ID: 22105851
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W; Glantz M; Greenberg H; Selker RG; Vick NA; Rampling R; Friedman H; Phillips P; Bruner J; Yue N; Osoba D; Zaknoen S; Levin VA
Br J Cancer; 2000 Sep; 83(5):588-93. PubMed ID: 10944597
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma survival in the United States before and during the temozolomide era.
Johnson DR; O'Neill BP
J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.
Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G
J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763
[TBL] [Abstract][Full Text] [Related]
12. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.
Masi BC; Tyler BM; Bow H; Wicks RT; Xue Y; Brem H; Langer R; Cima MJ
Biomaterials; 2012 Aug; 33(23):5768-75. PubMed ID: 22591609
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic management of gliosarcoma in the temozolomide era.
McAleer MF; Brown PD
CNS Oncol; 2015; 4(3):171-8. PubMed ID: 25905568
[TBL] [Abstract][Full Text] [Related]
14. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
Sher DJ; Henson JW; Avutu B; Hochberg FH; Batchelor TT; Martuza RL; Barker FG; Loeffler JS; Chakravarti A
J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
Prados MD; Chang SM; Butowski N; DeBoer R; Parvataneni R; Carliner H; Kabuubi P; Ayers-Ringler J; Rabbitt J; Page M; Fedoroff A; Sneed PK; Berger MS; McDermott MW; Parsa AT; Vandenberg S; James CD; Lamborn KR; Stokoe D; Haas-Kogan DA
J Clin Oncol; 2009 Feb; 27(4):579-84. PubMed ID: 19075262
[TBL] [Abstract][Full Text] [Related]
17. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.
Cohen KJ; Pollack IF; Zhou T; Buxton A; Holmes EJ; Burger PC; Brat DJ; Rosenblum MK; Hamilton RL; Lavey RS; Heideman RL
Neuro Oncol; 2011 Mar; 13(3):317-23. PubMed ID: 21339192
[TBL] [Abstract][Full Text] [Related]
19. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.
Guckenberger M; Mayer M; Buttmann M; Vince GH; Sweeney RA; Flentje M
Strahlenther Onkol; 2011 Sep; 187(9):548-54. PubMed ID: 21858417
[TBL] [Abstract][Full Text] [Related]
20. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]